Mounjaro Launches in India: A Breakthrough for Diabetes and Obesity Management
20 Mar 2025
India has witnessed a significant stride in the healthcare sector with the launch of Mounjaro, a groundbreaking anti-diabetes and obesity drug, by the US-based pharmaceutical giant Eli Lilly. The drug, containing the active ingredient tirzepatide, received marketing authorization from India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO). Mounjaro...
Read More
